BE885851A - Composition therapeutique pour le traitement de la dustrophie musculaire, de la myopathie et de la myotonie - Google Patents

Composition therapeutique pour le traitement de la dustrophie musculaire, de la myopathie et de la myotonie

Info

Publication number
BE885851A
BE885851A BE0/202577A BE202577A BE885851A BE 885851 A BE885851 A BE 885851A BE 0/202577 A BE0/202577 A BE 0/202577A BE 202577 A BE202577 A BE 202577A BE 885851 A BE885851 A BE 885851A
Authority
BE
Belgium
Prior art keywords
dustrophy
myotonia
myopathy
muscular
treatment
Prior art date
Application number
BE0/202577A
Other languages
English (en)
Inventor
P Huve
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of BE885851A publication Critical patent/BE885851A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/202577A 1979-11-02 1980-10-23 Composition therapeutique pour le traitement de la dustrophie musculaire, de la myopathie et de la myotonie BE885851A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA339073 1979-11-02

Publications (1)

Publication Number Publication Date
BE885851A true BE885851A (fr) 1981-02-16

Family

ID=4115526

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/202577A BE885851A (fr) 1979-11-02 1980-10-23 Composition therapeutique pour le traitement de la dustrophie musculaire, de la myopathie et de la myotonie

Country Status (3)

Country Link
US (1) US4344947A (fr)
JP (1) JPS5690013A (fr)
BE (1) BE885851A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE788648A (fr) * 1971-10-09 1973-01-02 Soc D Etudes Prod Chimique Derives de l'isopropylamino pyrimidine, leur preparation leur composition et leur utilisation therapeutique
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Also Published As

Publication number Publication date
JPS5690013A (en) 1981-07-21
US4344947A (en) 1982-08-17

Similar Documents

Publication Publication Date Title
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
JPS53136521A (en) Composition of treating multiplicable skin disease
JPS5581649A (en) Polymer composition for medical treatment and its preparation
LU80081A1 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
BE876157Q (fr) Medicament pour le traitement de l'acne
BE884917A (fr) Agent pour le traitement de theilerioses et son application
GB2029218B (en) Pharmaceutical composition for treatment of cardiovascular disease
FR2400517A1 (fr) Triazolo-2,4-benzodiazepines et leur utilisation therapeutique
BE854268A (fr) Pyrrolidones, leur procede de preparation et leur application therapeutique
TR20880A (tr) Akrilonitrilin aritilmasi
BE868843A (fr) Compositions pour le traitement de defaillances cardiaques et de cardiopathies ischemiques
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE851775A (fr) Composition pour le traitement de la chevelure
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
FR2349587A1 (fr) 1,3-dihydro-heteroarylspiro(isobenzofurannes), leur procede de preparation et leur application therapeutique
JPS5459309A (en) Selene composition for treatment and use thereof
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE871753A (fr) Nouvelle utilisation therapeutique de l'acetyl-1-carnitine pour le traitement des affections cardiaques
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
BE856957A (fr) Electrode pour traitement d'ionophorese
PH16250A (en) Pharmaceutical composition of therapeutic value in the treatment of some shock conditions
LU78873A1 (fr) Alkylthio-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,leur procede de preparation et application en therapeutique
BE868593A (fr) Alpha-vinyl-amino-acides, leur obtention et leur utilisation pour le traitement de la maladie de parkinson et d'etats depressifs

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SOC. D ETUDES DE PRODUITS CHIMIQUES

Effective date: 19901031